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Synthesis of Novel Classes of Pyrido[2,3-d]-
pyrimidines, Pyrano[2,3-d]pyrimidines,
and Pteridines
Mohit Lal Deb and Pulak J. Bhuyan
Medicinal Chemistry Division, Regional Research Laboratory, Jorhat,
Assam, India
Abstract: 6-Amino-5-formyluracils 1 and 5-formyl-6-hydroxyuracils 4 react with
Meldrum’s acid 2 in the presence of piperidine as catalyst under thermolytic conditions
to afford 6-carboxy-2,4,7-trioxopyrido[2,3-d ]pyrimidines 3 and 6-carboxy-2,4,7-
trioxopyrano[2,3-d ]pyrimidines 5 in good yield. Under identical conditions, 6-amino-
5-nitrosouracils 6 react with 2 to afford pteridine-6-carboxylic acids 7 in good yields.
Keywords: Meldrum’s acid, pteridines, pyrano[2,3-d]pyrimidines, pyrido[2,3-d]pyri-
midines, uracil
The importance of uracil and its annelated substrates is well recognized by
synthetic and biological chemists.[1] Pyrido[2,3-d]pyrimidines, pyrano[2,3-d]
pyrimidines, and pteridines represent broad classes of annelated uracils and
have received considerable attention over the past years because of their
wide range of biological activities. A number of compounds with these ring
systems have diverse pharmacological activity such as antibacterial,[2]
antitumor,[3] cardiotonic,[4] hepatoprotective,[4a] antihypertensive,[4a] and
anti-bronchits.[5] Some of them exhibit antialergic,[6] antimalerial,[7]
analgesic,[8] and antifungal[9] properties. Therefore, large efforts have been
directed toward the synthetic manipulation of uracils for the preparation of
these molecules.[10] In this regard, the synthetic exploitation of the nucleophi-
lic double bond of uracil is an important reaction strategy.[11]
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Meldrum’s acid appears to be an attractive reagent in organic
synthesis because of its high acidity, steric rigidity, and high
reactivity.[12]
As a part of our continued interest in the development of highly
expedient methods for the synthesis of annelated uracils of biological
significance,[13] we recently utilized 6-amino-5-formyluracils and 5-formyl-
6-hydroxyuracils as 1,4-dienes in a [4þ 2] cycloaddition reaction.[14] In
the present article, we report the synthesis of novel classes of 6-carboxy-
2,4,7-trioxopyrido[2,3-d ]-pyrimidines, 6-carboxy-2,4,7-trioxopyrano[2,3-d ]
pyrimidines, and pteridine-6-carboxylic acids (lumazines) from 6-amino-5-
formyluracils, 5-formyl-6-hydroxyuracils, and 6-amino-5-nitroso-uracils
based on the cyclocondensation reaction, which allows access to a range of
structural variation (Scheme 1).
Scheme 1.
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6-Amino-5-formyluracil 1a was prepared from 6-amino-1,3-dimethylur-
acil[15] under the Vilsmeier–Haack formylation reaction condition.[16] In a
typical experimental procedure, equimolar amounts of 6-amino-5-formyl
uracil 1a and Meldrum’s acid 2 were refluxed in a mixture of methanol and
chloroform (1:1) to afford 6-carboxy-2,4,7-trioxopyrido[2,3-d ]pyrimidines
3a in good yield. The structure of the compound 3a was determined from
the spectroscopic data and elemental analysis. The 1H NMR spectrum
showed the absence of the aldehyde proton and presence of a proton at d
7.40 as a singlet and another broad peak for one proton at d 8.95. The other
signals appeared at d 3.00 (s, 3H, N-CH3) and 3.15 (s, 3H, NCH3). The
mass spectrum revealed a strong molecular ion peak at (MþH)þ 252
(employing the positive ionization technique). The compound, on treatment
with aqueous NaHCO3 solution, evolves CO2 with effervescence, which
evidences the presence of a carboxylic acid group. Similarly, compounds
3b,c were synthesized from the reaction of 1b,c with 2 and characterized in
Table 1.
Under identical conditions, 1,3-dimethyl-5-formyl-6-hydroxyuracil
4a,[17] prepared from 1,3-dimethyl-6-hydroxyuracil, reacts with Meldrum’s
acid 2 to afford 6-carboxy-2,4,7-trioxo-pyrano[2,3-d]pyrimidine 5a in good
yields. The structure of the product was ascertained by spectroscopic and
elemental analysis. The 1H NMR spectrum showed the absence of the
aldehyde proton and the presence of a proton at d 7.95 as a singlet and a
broad peak for one proton at d 9.20. The other signals appeared at d 3.05
(s, 3H, N-CH3) and 3.10 (s, 3H, NCH3). The mass spectrum exhibited a
strong molecular ion peak at (MþH)þ 253. Similarly, 6-carboxy-2,4,7-
trioxopyrano[2,3-d]pyrimidines 5b,c were synthesized from the reaction of
4b,c with 2 and characterized in Table 1.
To explore the synthetic utility of the condensation process further, we
studied the reactivity pattern of comparatively less reactive 6-amino-5-nitroso
uracils 6 with Meldrum’s acid 2 and found them to react moderately to afford
Table 1. Pyrido[2,3-d ]pyrimidines 3, pyrano[2,3-d ]pyrimidines 5, and pteridines 7
Entry Product R1 R2
Reaction
time (h)
Yield
(%) Mp (8C)
1 3a CH3 CH3 18 61 345–347
2 3b H H 18 63 .350
3 3c C2H5 H 18 57 .350
4 5a CH3 CH3 20 63 278–280
5 5b CH3 H 20 60 337–339
6 5c C2H5 H 20 56 .350
7 7a CH3 CH3 21 70 326
8 7b H H 22 73 .330
9 7c C2H5 H 21 69 .330
Synthesis of Novel Classes of Annelated Uracils 3087
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the ptridiene-6-carboxylic acid (lumazine) derivatives 7 in good yields. The
structures of the compounds were confirmed from the spectroscopic data and
elemental analysis (Table 1). The 1H NMR of compound 7a showed the
presence of one proton at d 9.10 as a singlet. The mass spectrum showed a
strong molecular ion peak at (MþH)þ 253. The IR spectrum showed the
absence of the -NH2 group and N55O group of the uracil derivative.
In conclusion, we have reported the synthesis of some novel classes of
6-carboxy-2,4,7-trioxo pyrido[2,3-d]pyrimidines, 6-carboxy-2,4,7-trioxo
pyrano[2,3-d]pyrimidines, and lumazine derivatives by utilizing easily
available organic synthones such as Meldrum’s acid with suitably functiona-
lized uracil derivatives.
EXPERIMENTAL SECTION
1,3-Dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]
pyrimidine-6-carboxylic Acid 3
In a typical experimental procedure, equimolar amounts of 1,3-dimethyl-6-
amino-5-formyl uracil 1a (2 mmol, 366 mg) and Meldrum’s acid 2 (2 mmol,
288 mg) in the presence of piperidine (2 drops) were refluxed in a mixture
of methanol and chloroform (1:1, 15 ml) for 18 h. The solvent was evaporated
under reduced pressure, and the obtained solid compound was purified by pre-
parative thin-layer chromatography (TLC) using chloroform–ethyl acetate
(1:5) as eluent. The product 3a was obtained in 61% yield (305.5 mg). Mp
345–3478C. 1H NMR (300 MHz, CDCl3þ CH3OD) d 3.00 (s, 3H), 3.15
(s, 3H), 7.40 (s, 1H), 8.95 (s, br, 1H). 13C NMR (75 MHz) d 28.5 (N-Me),
36.8 (N-Me), 107.20 (C-10), 142.15 (C-6), 143.00 (C-7), 144.50 (C-5),
150.20 (C-2), 154.00 (C-9), 157.25 (C-4), 168.00 (-COOH). IR KBr vmax
cm21 3400 (br), 1705, 1690, 1655. MS: (MþH)þ 252. Anal. calcd. for
C10H9N3O5 C, 47.80; H, 3.58; N, 16.73. Found C, 47.75; H, 3.45; N, 16.70.
1,3-Dimethyl-2,4,7-trioxo-1,2,3,4-tetrahydro-2H-pyrano[2,3-d ]
pyrimidine-6-carboxylic Acid 5
In a simple experimental procedure, equimolar amounts of 1,3-dimethyl-5-
formyl-6-hydroxyuracil 4 (2 mmol, 368 mg) and Meldrum’s acid 2
(2 mmol, 288 mg) in the presence of piperidine (2 drops) were refluxed in
15 ml of ethanol for 20 h. The solvent was evaporated under reduced
pressure, and the solid compound obtained was purified by preparative TLC
using chloroform–ethyl acetate (1:3) as eluent. The product 5a was
obtained in 63% yield (317 mg). Mp 278–2808C. 1H NMR (300 MHz,
CDCl3þ CH3OD) d 3.05 (s, 3H), 3.10 (s, 3H), 7.95 (s, 1H), 9.20 (s, br,
1H). 13C NMR (75 MHz) d 29.18 (N-Me), 36.53 (N-Me), 107.00 (C-10),
M. L. Deb and P. J. Bhuyan3088
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144.23 (C-6), 145.00 (C-5), 151.10 (C-2), 153.80 (C-9), 156.75 (C-4), 169.17
(-COOH), 171.00 (C-7). IR KBr vmax cm
21 3450 (br), 1750, 1705, 1690, 1660.
MS: (MþH)þ 253. Anal. calcd. for C10H8N2O6 C, 47.61; H, 3.17; N, 11.11.
Found C, 47.58; H, 3.14; N, 11.05.
1,3-Dimethyl-2,4,7-trioxo-1,2,3,4,7,8 hexahydropteridine-6-
carboxylic Acid 7
In a typical experimental procedure, equimolar amounts of 1,3-dimethyl-6-
amino-5-nitroso uracil 6a (2 mmol, 368 mg) and Meldrum’s acid 2
(2 mmol, 288 mg) and 0.25 mmol of NaOH were refluxed in water for 21 h.
The solvent was evaporated under reduced pressure, and the solid
compound obtained was purified by column chromatography using chloro-
form–ethyl acetate (1:3) as eluent. The product 7a was obtained in 70%
yield (401 mg). Mp 3268C. 1H NMR (300 MHz, CDCl3þ CH3OD) d 3.00
(s, 3H), 3.10 (s, 3H), 8.10 (s, 1H). 13C NMR (75 MHz) d 29.00 (N-Me),
36.50 (N-Me), 108.50 (C-10), 142.50 (C-6), 143.00 (C-7), 149.50 (C-2),
155.00 (C-9), 157.50 (C-4), 168.00 (-COOH). IR KBr vmax cm
21 3430,
1735, 1695, 1660. MS: (MþH)þ 253. Anal. calcd. for C15H17N3O3 C,
62.71; H, 5.92; N, 14.63. Found: C, 62.68; H, 5.87; N, 14.70.
ACKNOWLEDGMENTS
The authors thank the director, Regional Research Laboratory (RRL),
Jorhat, for providing the facilities to perform the work. M. L. Deb thanks
Council of Scientific & Industrial Research (CSIR), New Delhi, for the
award of a junior research fellowship.
REFERENCES
1. (a) Marumoto, R.; Furukawa, Y.Chem.Pharm.Bull. 1977,25, 29734; (b) Griengl, R.;
Wack, E.; Schwarz, W.; Streicher, W.; Rosenwirth, B.; De Clercq, E. J. Med. Chem.
1987, 30, 1199; (c) De Clercq, E.; Bernaerts, R. J. Biol. Chem. 1987, 262, 14905;
(d) Jones, A. S.; Sayers, J. R.; Walker, R. T.; De Clercq, E. J. Med. Chem. 1988,
31, 268; (e) Mitsuya, H.; Yarchoan, R.; Broder, S. Science 1990, 249, 1533;
(f) Pontikis, R.; Monneret, C. Tetrahedron Lett. 1994, 35, 4351.
2. (a) Gavrilov, M. Y.; Novoseleva, G. N.; Vakhrin, M. I.; Konshin, M. E. Khim.
Farm. Zh. 1996, 30, 39; (b) Ghorab, M. M.; Hassan, A. Y. Phosphorus, Sulfur
Silicon Relat. Elem. 1998, 141, 257.
3. (a) Anderson, G. L.; Shim, J. L.; Broom, A. D. J. Org. Chem. 1976, 41, 1095;
(b) Grivaky, E. M.; Lee, S.; Siyal, C. W.; Duch, D. S.; Nichol, C. A. J. Med.
Chem. 1980, 23, 327.
Synthesis of Novel Classes of Annelated Uracils 3089
D
ow
nl
oa
de
d 
By
: [
N
at
io
na
l C
he
m
ic
al
 L
ab
or
at
or
y]
 A
t: 
18
:3
3 
5 
Ju
ne
 2
00
7 
4. (a) Furuya, S.; Ohtaki, T. Eur. Pat. Appl., EP. 1994, 608565; Chem. Abstr., 1994
121, 205395; (b) Heber, D.; Heers, C.; Ravens, U. Pharmazie 1993, 48, 537.
5. Sukuma, Y.; Hasegawa, M.; Kataoka, K.; Hoshina, K.; Yamazaki, N.; Kadota, T.;
Yamaguchi, H. PCT. Int. Appl. 1989, WO 9105785, Chem. Abstr. 1991, 115,
71646.
6. Bennett, L. R.; Blankely, C. J.; Fleming, R. W.; Smith, R. D.; Tessonam, D. K.
J. Med. Chem. 1981, 24, 382.
7. Davoll, J.; Clarke, J.; Eislager, F. E. J. Med. Chem. 1972, 15, 837.
8. (a) Kretzschmer, E. Pharmazie 1980, 35, 253; (b) Shigo, S.; Hiroshi, I. Yakugaku
Zasshi. 1969, 89, 266.
9. Ahluwalia, V. K.; Batla, R.; Khurana, A.; Kumar, R. Indian J. Chem., Sec. B 1990,
29, 1141.
10. (a) Cheng, T.; Wang, Y.; Cai, M. Youji. Huaxue 1988, 8, 250; (b) Spada, M. R.;
Klein, R. S.; Otter, B. A. J. Heterocycl. Chem. 1989, 26, 1851;
(c) Ahluwalia, V. K.; Kumar, R.; Khurana, K.; Bhatia, R. Tetrahedron 1990, 46,
3963; (d) Ahluwalia, V. K.; Bhatia, R.; Khurana, A.; Kumar, R. Indian J. Chem.
Sec. B 1990, 29, 1141; (e) Ahluwalia, V. K.; Sharma, H. R.; Tyagi, R. Tetrahedron
1986, 42, 4045; (f) Ahluwalia, V. K.; Aggarwal, R.; Alauddin, M.; Gill, G.;
Khanduri, C. H. Heterocycles 1990, 31, 129; (g) Broom, A. D.; Shim, J. L.;
Anderson, C. L. J. Org. Chem. 1976, 411, 1095; (h) Wamhoff, H.; Muhr, J.
Synthesis 1988, 919; (i) Hirota, K.; Kuki, H.; Maki, Y. Heterocycles 1994, 37,
563; (j) Srivastava, P.; Saxena, A. S.; Ram, V. J. Synthesis 2000, 541.
11. (a) Wamhoff, H.; Winfried, S. J. Org. Chem. 1986, 51, 2787; (b) Hirota, K.;
Benno, K.; Yumuda, Y.; Senda, S. J. Chem. Soc., Perkin. Trans. 1 1985, 1137;
(c) Walsh, E. B.; Wamhoff, H. Chem. Ber. 1989, 122, 1673; (d) Thakur, A. J.;
Saikia, P.; Prajapati, D.; Sandhu, J. S. Synlett 2001, 1299; (e) Bhuyan, P. J.;
Boruah, R. C.; Sandhu, J. S. J. Org. Chem. 1990, 55, 568.
12. Chen, B. C. Heterocycles 1991, 32, 529.
13. (a) Bhuyan, P. J.; Borah, H. N.; Sandhu, J. S. Tetrahedron Lett. 2002, 43, 895;
(b) Bhuyan, P. J.; Borah, H. N.; Boruah, R. C. Tetrahedron Lett. 2003, 44,
1847; (c) Devi, I.; Bhuyan, P. J. Synlett 2004, 283.
14. Devi, I.; Borah, H. N.; Bhuyan, P. J. Tetrahedron Lett. 2004, 45, 2405.
15. Pipesch, V.; Schroeder, E. F. J. Org. Chem. 1951, 1879.
16. Delia, T. J.; Otteman, R. Heterocycles 1983, 1805.
17. Senda, S.; Hirota, K.; Yang, G. N.; Shirahashi, M. Yakugaku Zasshi 1971, 91,
1372; Chem. Abstr. 1972, 76, 126915q.
M. L. Deb and P. J. Bhuyan3090
